BRAINSTORM CELL THERAPEUTICS INC
BRAINSTORM CELL THERAPEUTICS INC (BCLI) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 244 transactions totaling $4.0M, demonstrating a bullish sentiment with $65.3K in net insider flow. The most recent transaction on Jul 19, 2024 involved a sale of 63,000 shares valued at $22.1K.
BCLI Insider Activity Summary
Who Is Buying BCLI Stock?
No significant insider buying has been recorded for BCLI in the recent period.
Who Is Selling BCLI Stock?
No significant insider selling has been recorded for BCLI in the recent period.
Is BRAINSTORM CELL THERAPEUTICS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BCLI is bullish with an Insider Alignment Score of 51/100 and a net flow of $65.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
BCLI Frequently Asked Questions
Understanding BCLI Insider Activity
Insider trading at BRAINSTORM CELL THERAPEUTICS INC (BCLI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading BCLI stock, having executed 244 transactions in the past 90 days. The most active insider is Corp. Accbt (Executive), who has made 15 transactions totaling $4.5M.
Related Tools
Track BRAINSTORM CELL THERAPEUTICS INC Insider Activity
Get notified when executives and directors at BCLI file new Form 4 transactions